{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Medicinal plants", "Multiple sclerosis", "Prebiotics", "Probiotics", "Warburg effect"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35935051", "DateRevised": {"Year": "2022", "Month": "08", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.34172/apb.2022.057"], "Journal": {"ISSN": "2228-5881", "JournalIssue": {"Volume": "12", "Issue": "3", "PubDate": {"Year": "2022", "Month": "May"}}, "Title": "Advanced pharmaceutical bulletin", "ISOAbbreviation": "Adv Pharm Bull"}, "ArticleTitle": "Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect.", "Pagination": {"StartPage": "515", "EndPage": "523", "MedlinePgn": "515-523"}, "Abstract": {"AbstractText": ["Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). It is an auto-immune disorder. Its usual symptoms are unique to each person. In MS lesions vast fractions of pyruvate molecules are instantly transformed into lactate. This reprogramming mechanism of glycolysis is known as the Warburg effect. MS has no efficient treatment yet. Hence, there is a requirement for profitable immunomodulatory agents in MS. Probiotics perform as an immunomodulator because they regulate the host's immune responses. Its efficacy gets enhanced for an extended period when it combines with prebiotics. In this review, we focus on the metabolic alterations behind the MS lesions via the Warburg effect, and also suggesting, the combined efficacy of prebiotics and probiotics for the effective treatment of MS without side effects. The Warburg effect mechanism intensifies the infiltration of activated T-cells and B-cells into the CNS. It provokes the inflammation process on the myelin sheath. The infiltration of immune cells can be inhibited by the combination therapy of probiotics and prebiotics. By this review, we can recommend that the idea of this combinational therapy can do miracles in the treatment of MS in the future."], "CopyrightInformation": "\u00a92022 The Authors."}, "AuthorList": [{"Identifier": ["0000-0001-6625-8918"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Bharathiar University, Coimbatore, India."}], "LastName": "Ravi", "ForeName": "Anjali Kandiruthi", "Initials": "AK"}, {"Identifier": ["0000-0002-2639-3186"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Bharathiar University, Coimbatore, India."}], "LastName": "Muthukrishnan", "ForeName": "Saradhadevi Kuppusami", "Initials": "SK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Adv Pharm Bull", "NlmUniqueID": "101578021", "ISSNLinking": "2228-5881"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV. et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014;83(11):1022\u20134. doi: 10.1212/wnl.0000000000000768.", "ArticleIdList": ["10.1212/wnl.0000000000000768", "PMC4162299", "25200713"]}, {"Citation": "Koch-Henriksen N, S\u00f8rensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9(5):520\u201332. doi: 10.1016/s1474-4422(10)70064-8.", "ArticleIdList": ["10.1016/s1474-4422(10)70064-8", "20398859"]}, {"Citation": "Ebers GC. Prognostic factors for multiple sclerosis: the importance of natural history studies. J Neurol. 2005;252 Suppl 3:iii15\u2013iii20. doi: 10.1007/s00415-005-2012-4.", "ArticleIdList": ["10.1007/s00415-005-2012-4", "16170495"]}, {"Citation": "Crespo-Bujosa HB, Gonzalez MJ. Phytochemicals for the treatment of multiple sclerosis? A review of scientific evidence. J Orthomol Med. 2018;33(1):1\u20138."}, {"Citation": "Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001;81(2):871\u2013927. doi: 10.1152/physrev.2001.81.2.871.", "ArticleIdList": ["10.1152/physrev.2001.81.2.871", "11274346"]}, {"Citation": "Hohlfeld R, Wekerle H. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc Natl Acad Sci U S A. 2004;101(Suppl 2):14599\u2013606. doi: 10.1073/pnas.0404874101.", "ArticleIdList": ["10.1073/pnas.0404874101", "PMC521993", "15306684"]}, {"Citation": "Loch-Neckel G, Koepp J. [The blood-brain barrier and drug delivery in the central nervous system] Rev Neurol. 2010;51(3):165\u201374.", "ArticleIdList": ["20645267"]}, {"Citation": "Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 2011;585(23):3770\u201380. doi: 10.1016/j.febslet.2011.04.066.", "ArticleIdList": ["10.1016/j.febslet.2011.04.066", "21550344"]}, {"Citation": "F\u00fcnfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J. et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485(7399):517\u201321. doi: 10.1038/nature11007.", "ArticleIdList": ["10.1038/nature11007", "PMC3613737", "22622581"]}, {"Citation": "Pfeiffer T, Schuster S, Bonhoeffer S. Cooperation and competition in the evolution of ATP-producing pathways. Science. 2001;292(5516):504\u20137. doi: 10.1126/science.1058079.", "ArticleIdList": ["10.1126/science.1058079", "11283355"]}, {"Citation": "Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS. et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 2008;451(7182):1076\u201381. doi: 10.1038/nature06559.", "ArticleIdList": ["10.1038/nature06559", "18278032"]}, {"Citation": "Benveniste EN, Liu Y, McFarland BC, Qin H. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. J Interferon Cytokine Res. 2014;34(8):577\u201388. doi: 10.1089/jir.2014.0012.", "ArticleIdList": ["10.1089/jir.2014.0012", "PMC4118716", "25084174"]}, {"Citation": "Leibowitz SM, Yan J. NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications. Front Mol Neurosci. 2016;9:84. doi: 10.3389/fnmol.2016.00084.", "ArticleIdList": ["10.3389/fnmol.2016.00084", "PMC5023675", "27695399"]}, {"Citation": "Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P. et al. Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis. Oncotarget. 2018;9(9):8263\u201377. doi: 10.18632/oncotarget.23862.", "ArticleIdList": ["10.18632/oncotarget.23862", "PMC5823598", "29492193"]}, {"Citation": "Bhatia R, Singh N. Multiple sclerosis: newer concepts on pathophysiology, diagnostic criteria and therapeutics. Astrocyte. 2018;5(1):43\u201354. doi: 10.4103/astrocyte.astrocyte_51_18.", "ArticleIdList": ["10.4103/astrocyte.astrocyte_51_18"]}, {"Citation": "Mojaverrostami S, Nazm Bojnordi M, Ghasemi-Kasman M, Ebrahimzadeh MA, Ghasemi Hamidabadi H. A review of herbal therapy in multiple sclerosis. Adv Pharm Bull. 2018;8(4):575\u201390. doi: 10.15171/apb.2018.066.", "ArticleIdList": ["10.15171/apb.2018.066", "PMC6311642", "30607330"]}, {"Citation": "Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R. et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7:12015. doi: 10.1038/ncomms12015.", "ArticleIdList": ["10.1038/ncomms12015", "PMC4931233", "27352007"]}, {"Citation": "Ngo DC, Ververis K, Tortorella SM, Karagiannis TC. Introduction to the molecular basis of cancer metabolism and the Warburg effect. Mol Biol Rep. 2015;42(4):819\u201323. doi: 10.1007/s11033-015-3857-y.", "ArticleIdList": ["10.1007/s11033-015-3857-y", "25672512"]}, {"Citation": "Magistretti PJ, Allaman I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci. 2018;19(4):235\u201349. doi: 10.1038/nrn.2018.19.", "ArticleIdList": ["10.1038/nrn.2018.19", "29515192"]}, {"Citation": "Otto AM. Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab. 2016;4:5. doi: 10.1186/s40170-016-0145-9.", "ArticleIdList": ["10.1186/s40170-016-0145-9", "PMC4784299", "26962452"]}, {"Citation": "Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11(8):633\u201352. doi: 10.1038/nrd3800.", "ArticleIdList": ["10.1038/nrd3800", "PMC3644509", "22850787"]}, {"Citation": "Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115(23):4742\u20139. doi: 10.1182/blood-2009-10-249540.", "ArticleIdList": ["10.1182/blood-2009-10-249540", "PMC2890190", "20351312"]}, {"Citation": "Palsson-McDermott EM, O\u2019Neill LA. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays. 2013;35(11):965\u201373. doi: 10.1002/bies.201300084.", "ArticleIdList": ["10.1002/bies.201300084", "24115022"]}, {"Citation": "Aghamohammadi D, Ayromlou H, Dolatkhah N, Jahanjoo F, Shakouri SK. The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial. Trials. 2019;20(1):379. doi: 10.1186/s13063-019-3454-9.", "ArticleIdList": ["10.1186/s13063-019-3454-9", "PMC6591959", "31234904"]}, {"Citation": "Nijland PG, Molenaar RJ, van der Pol SM, van der Valk P, van Noorden CJ, de Vries HE. et al. Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions. Acta NeuropatholCommun. 2015;3:79. doi: 10.1186/s40478-015-0261-8.", "ArticleIdList": ["10.1186/s40478-015-0261-8", "PMC4670517", "26637184"]}, {"Citation": "Schocke MF, Berger T, Felber SR, Wolf C, Deisenhammer F, Kremser C. et al. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy. Neuroimage. 2003;20(2):1253\u201363. doi: 10.1016/s1053-8119(03)00409-9.", "ArticleIdList": ["10.1016/s1053-8119(03)00409-9", "14568494"]}, {"Citation": "Peruzzotti-Jametti L, Pluchino S. Targeting mitochondrial metabolism in neuroinflammation: towards a therapy for progressive multiple sclerosis. Trends Mol Med. 2018;24(10):838\u201355. doi: 10.1016/j.molmed.2018.07.007.", "ArticleIdList": ["10.1016/j.molmed.2018.07.007", "30100517"]}, {"Citation": "Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity. 2007;27(2):173\u20138. doi: 10.1016/j.immuni.2007.07.008.", "ArticleIdList": ["10.1016/j.immuni.2007.07.008", "17723208"]}, {"Citation": "Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333. doi: 10.1126/science.1160809.", "ArticleIdList": ["10.1126/science.1160809", "PMC2849637", "19460998"]}, {"Citation": "Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain. 2009;132(Pt 12):3329\u201341. doi: 10.1093/brain/awp289.", "ArticleIdList": ["10.1093/brain/awp289", "19933767"]}, {"Citation": "De Riccardis L, Rizzello A, Ferramosca A, Urso E, De Robertis F, Danieli A. et al. Bioenergetics profile of CD4(+) T cells in relapsing remitting multiple sclerosis subjects. J Biotechnol. 2015;202:31\u20139. doi: 10.1016/j.jbiotec.2015.02.015.", "ArticleIdList": ["10.1016/j.jbiotec.2015.02.015", "25701681"]}, {"Citation": "Zekki H, Feinstein DL, Rivest S. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol. 2002;12(3):308\u201319. doi: 10.1111/j.1750-3639.2002.tb00445.x.", "ArticleIdList": ["10.1111/j.1750-3639.2002.tb00445.x", "PMC8095733", "12146799"]}, {"Citation": "Miranda-Hernandez S, Baxter AG. Role of toll-like receptors in multiple sclerosis. Am J Clin Exp Immunol. 2013;2(1):75\u201393.", "ArticleIdList": ["PMC3714200", "23885326"]}, {"Citation": "Nagyoszi P, Wilhelm I, Farkas AE, Fazakas C, Dung NT, Hask\u00f3 J. et al. Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem Int. 2010;57(5):556\u201364. doi: 10.1016/j.neuint.2010.07.002.", "ArticleIdList": ["10.1016/j.neuint.2010.07.002", "20637248"]}, {"Citation": "Comabella M, L\u00fcnemann JD, R\u00edo J, S\u00e1nchez A, L\u00f3pez C, Juli\u00e0 E. et al. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain. 2009;132(Pt 12):3353\u201365. doi: 10.1093/brain/awp228.", "ArticleIdList": ["10.1093/brain/awp228", "19741051"]}, {"Citation": "Vall\u00e9e A, Lecarpentier Y, Guillevin R, Vall\u00e9e JN. Demyelination in multiple sclerosis: reprogramming energy metabolism and potential PPAR\u03b3 agonist treatment approaches. Int J Mol Sci. 2018;19(4):1212. doi: 10.3390/ijms19041212.", "ArticleIdList": ["10.3390/ijms19041212", "PMC5979570", "29659554"]}, {"Citation": "Lecarpentier Y, Krokidis X, Martin P, Pineau T, H\u00e9bert JL, Quillard J. et al. Increased entropy production in diaphragm muscle of PPAR alpha knockout mice. J Theor Biol. 2008;250(1):92\u2013102. doi: 10.1016/j.jtbi.2007.09.022.", "ArticleIdList": ["10.1016/j.jtbi.2007.09.022", "17980390"]}, {"Citation": "Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D. et al. Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. J Neurosci. 2016;36(17):4698\u2013707. doi: 10.1523/jneurosci.4077-15.2016.", "ArticleIdList": ["10.1523/jneurosci.4077-15.2016", "PMC6601725", "27122029"]}, {"Citation": "Thompson CB. Wnt meets Warburg: another piece in the puzzle? EMBO J. 2014;33(13):1420\u20132. doi: 10.15252/embj.201488785.", "ArticleIdList": ["10.15252/embj.201488785", "PMC4194084", "24843042"]}, {"Citation": "Yuan S, Shi Y, Tang SJ. Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain. J Neuroimmune Pharmacol. 2012;7(4):904\u201313. doi: 10.1007/s11481-012-9370-3.", "ArticleIdList": ["10.1007/s11481-012-9370-3", "22547300"]}, {"Citation": "Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest. 2012;122(4):1164\u201371. doi: 10.1172/jci58644.", "ArticleIdList": ["10.1172/jci58644", "PMC3314450", "22466658"]}, {"Citation": "O\u2019Shea JJ, Kontzias A, Yamaoka K, Tanaka Y, Laurence A. Janus kinase inhibitors in autoimmune diseases. Ann Rheum Dis. 2013;72 Suppl 2:ii111\u20135. doi: 10.1136/annrheumdis-2012-202576.", "ArticleIdList": ["10.1136/annrheumdis-2012-202576", "PMC3616338", "23532440"]}, {"Citation": "Zaheer S, Wu Y, Bassett J, Yang B, Zaheer A. Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis. Neurochem Res. 2007;32(12):2123\u201331. doi: 10.1007/s11064-007-9383-0.", "ArticleIdList": ["10.1007/s11064-007-9383-0", "17551829"]}, {"Citation": "Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E. et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179(7):4313\u20137. doi: 10.4049/jimmunol.179.7.4313.", "ArticleIdList": ["10.4049/jimmunol.179.7.4313", "17878325"]}, {"Citation": "Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH. et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest. 2001;108(5):739\u201347. doi: 10.1172/jci12563.", "ArticleIdList": ["10.1172/jci12563", "PMC209380", "11544280"]}, {"Citation": "Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13(11):460\u20139. doi: 10.1016/j.molmed.2007.09.002.", "ArticleIdList": ["10.1016/j.molmed.2007.09.002", "18029230"]}, {"Citation": "Ozenci V, Kouwenhoven M, Huang YM, Kivis\u00e4kk P, Link H. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol. 2000;120(1):147\u201353. doi: 10.1046/j.1365-2249.2000.01175.x.", "ArticleIdList": ["10.1046/j.1365-2249.2000.01175.x", "PMC1905623", "10759776"]}, {"Citation": "Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R. Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis. Front Immunol. 2015;6:492. doi: 10.3389/fimmu.2015.00492.", "ArticleIdList": ["10.3389/fimmu.2015.00492", "PMC4586507", "26483787"]}, {"Citation": "Vanderlugt CL, Rahbe SM, Elliott PJ, Dal Canto MC, Miller SD. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. J Autoimmun. 2000;14(3):205\u201311. doi: 10.1006/jaut.2000.0370.", "ArticleIdList": ["10.1006/jaut.2000.0370", "10756082"]}, {"Citation": "Fissolo N, Kraus M, Reich M, Ayturan M, Overkleeft H, Driessen C. et al. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. Eur J Immunol. 2008;38(9):2401\u201311. doi: 10.1002/eji.200838413.", "ArticleIdList": ["10.1002/eji.200838413", "18792018"]}, {"Citation": "Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia. 2017;116:77\u201384. doi: 10.1016/j.fitote.2016.11.010.", "ArticleIdList": ["10.1016/j.fitote.2016.11.010", "27890794"]}, {"Citation": "Liu Y, Zhang DT, Liu XG. mTOR signaling in T cell immunity and autoimmunity. Int Rev Immunol. 2015;34(1):50\u201366. doi: 10.3109/08830185.2014.933957.", "ArticleIdList": ["10.3109/08830185.2014.933957", "25019278"]}, {"Citation": "Goebbels S, Oltrogge JH, Kemper R, Heilmann I, Bormuth I, Wolfer S. et al. Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J Neurosci. 2010;30(26):8953\u201364. doi: 10.1523/jneurosci.0219-10.2010.", "ArticleIdList": ["10.1523/jneurosci.0219-10.2010", "PMC6632897", "20592216"]}, {"Citation": "Giuliani F, Metz LM, Wilson T, Fan Y, Bar-Or A, Yong VW. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. J Neuroimmunol. 2005;158(1-2):213\u201321. doi: 10.1016/j.jneuroim.2004.09.006.", "ArticleIdList": ["10.1016/j.jneuroim.2004.09.006", "15589056"]}, {"Citation": "Mohajeri M, Sadeghizadeh M, Najafi F, Javan M. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacology. 2015;99:156\u201367. doi: 10.1016/j.neuropharm.2015.07.013.", "ArticleIdList": ["10.1016/j.neuropharm.2015.07.013", "26211978"]}, {"Citation": "Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. MultScler. 2004;10(4):434\u201341. doi: 10.1191/1352458504ms1082oa.", "ArticleIdList": ["10.1191/1352458504ms1082oa", "15327042"]}, {"Citation": "M\u00e4hler A, Steiniger J, Bock M, Klug L, Parreidt N, Lorenz M. et al. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. Am J Clin Nutr. 2015;101(3):487\u201395. doi: 10.3945/ajcn.113.075309.", "ArticleIdList": ["10.3945/ajcn.113.075309", "25733633"]}, {"Citation": "Ghazavi A, Mosayebi G, Salehi H, Abtahi H. Effect of ethanol extract of saffron (Crocus sativus L.) on the inhibition of experimental autoimmune encephalomyelitis in C57bl/6 mice. Pak J Biol Sci. 2009;12(9):690\u20135. doi: 10.3923/pjbs.2009.690.695.", "ArticleIdList": ["10.3923/pjbs.2009.690.695", "19634472"]}, {"Citation": "Jafarzadeh A, Mohammadi-Kordkhayli M, Ahangar-Parvin R, Azizi V, Khoramdel-Azad H, Shamsizadeh A. et al. Ginger extracts influence the expression of IL-27 and IL-33 in the central nervous system in experimental autoimmune encephalomyelitis and ameliorates the clinical symptoms of disease. J Neuroimmunol. 2014;276(1-2):80\u20138. doi: 10.1016/j.jneuroim.2014.08.614.", "ArticleIdList": ["10.1016/j.jneuroim.2014.08.614", "25175065"]}, {"Citation": "Bertoglio JC, Baumgartner M, Palma R, Ciampi E, Carcamo C, C\u00e1ceres DD. et al. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study. BMC Neurol. 2016;16:77. doi: 10.1186/s12883-016-0595-2.", "ArticleIdList": ["10.1186/s12883-016-0595-2", "PMC4877819", "27215274"]}, {"Citation": "Kim JY, Yoon JY, Sugiura Y, Lee SK, Park JD, Song GJ. et al. Dendropanaxmorbiferus leaf extract facilitates oligodendrocyte development. R Soc Open Sci. 2019;6(6):190266. doi: 10.1098/rsos.190266.", "ArticleIdList": ["10.1098/rsos.190266", "PMC6599778", "31312492"]}, {"Citation": "Sirdaarta J, Matthews B, White A, Cock IE. GC-MS and LC-MS analysis of Kakadu plum fruit extracts displaying inhibitory activity against microbial triggers of multiple sclerosis. PharmacognCommun. 2015;5(2):100\u201315. doi: 10.5530/pc.2015.2.2.", "ArticleIdList": ["10.5530/pc.2015.2.2"]}, {"Citation": "Sedighi B, Pardakhty A, Kamali H, Shafiee K, Naz Hasani B. Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis. Iran J Neurol. 2014;13(3):149\u201353.", "ArticleIdList": ["PMC4240932", "25422734"]}, {"Citation": "Azadmehr A, Goudarzvand M, Saadat P, Ebrahimi H, Hajiaghaee R, Miri NS. et al. Immunomodulatory and anti-inflammatory effects of Scrophulariamegalantha ethanol extract on an experimental model of multiple sclerosis. Res J Pharmacogn. 2019;6(1):43\u201350. doi: 10.22127/rjp.2018.80370.", "ArticleIdList": ["10.22127/rjp.2018.80370"]}, {"Citation": "Ghaffari S, Hatami H, Dehghan G. Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide. Res Pharm Sci. 2015;10(3):222\u201332.", "ArticleIdList": ["PMC4621629", "26600849"]}, {"Citation": "Ghaiad HR, Nooh MM, El-Sawalhi MM, Shaheen AA. Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: biochemical and histological study. Mol Neurobiol. 2017;54(5):3219\u201329. doi: 10.1007/s12035-016-9891-5.", "ArticleIdList": ["10.1007/s12035-016-9891-5", "27067589"]}, {"Citation": "Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol. 2010;30(4):328\u201339. doi: 10.1097/WNO.0b013e3181f7f833.", "ArticleIdList": ["10.1097/WNO.0b013e3181f7f833", "PMC3312784", "21107122"]}, {"Citation": "Zajicek JP, Hobart JC, Slade A, Barnes D, Mattison PG. Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry. 2012;83(11):1125\u201332. doi: 10.1136/jnnp-2012-302468.", "ArticleIdList": ["10.1136/jnnp-2012-302468", "22791906"]}, {"Citation": "Tegenge MA, Rajbhandari L, Shrestha S, Mithal A, Hosmane S, Venkatesan A. Curcumin protects axons from degeneration in the setting of local neuroinflammation. Exp Neurol. 2014;253:102\u201310. doi: 10.1016/j.expneurol.2013.12.016.", "ArticleIdList": ["10.1016/j.expneurol.2013.12.016", "24382451"]}, {"Citation": "Itoh T, Fujimoto Y, Kawai Y, Toba T, Saito T. Inhibition of food-borne pathogenic bacteria by bacteriocins from Lactobacillus gasseri. Lett Appl Microbiol. 1995;21(3):137\u201341. doi: 10.1111/j.1472-765x.1995.tb01025.x.", "ArticleIdList": ["10.1111/j.1472-765x.1995.tb01025.x", "7576495"]}, {"Citation": "Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C. et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538\u201341. doi: 10.1038/nature10554.", "ArticleIdList": ["10.1038/nature10554", "22031325"]}, {"Citation": "Tankou SK, Regev K, Healy BC, Cox LM, Tjon E, Kivisakk P. et al. Investigation of probiotics in multiple sclerosis. MultScler. 2018;24(1):58\u201363. doi: 10.1177/1352458517737390.", "ArticleIdList": ["10.1177/1352458517737390", "29307299"]}, {"Citation": "Chae CS, Kwon HK, Hwang JS, Kim JE, Im SH. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis. PLoS One. 2012;7(12):e52119. doi: 10.1371/journal.pone.0052119.", "ArticleIdList": ["10.1371/journal.pone.0052119", "PMC3527378", "23284891"]}, {"Citation": "He B, Hoang TK, Tian X, Taylor CM, Blanchard E, Luo M. et al. Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota. Front Immunol. 2019;10:385. doi: 10.3389/fimmu.2019.00385.", "ArticleIdList": ["10.3389/fimmu.2019.00385", "PMC6416370", "30899262"]}, {"Citation": "Salehipour Z, Haghmorad D, Sankian M, Rastin M, Nosratabadi R, Soltan Dallal MM. et al. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomed Pharmacother. 2017;95:1535\u201348. doi: 10.1016/j.biopha.2017.08.117.", "ArticleIdList": ["10.1016/j.biopha.2017.08.117", "28946394"]}, {"Citation": "Tamtaji OR, Kouchaki E, Salami M, Aghadavod E, Akbari E, Tajabadi-Ebrahimi M. et al. The effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr. 2017;36(8):660\u20135. doi: 10.1080/07315724.2017.1347074.", "ArticleIdList": ["10.1080/07315724.2017.1347074", "28922099"]}, {"Citation": "Kwon HK, Kim GC, Kim Y, Hwang W, Jash A, Sahoo A. et al. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin Immunol. 2013;146(3):217\u201327. doi: 10.1016/j.clim.2013.01.001.", "ArticleIdList": ["10.1016/j.clim.2013.01.001", "23416238"]}, {"Citation": "Goudarzvand M, Rasouli Koohi S, Khodaii Z, Soleymanzadeh Moghadam S. Probiotics Lactobacillus plantarum and bifidobacterium B94: cognitive function in demyelinated model. Med J Islam Repub Iran. 2016;30:391.", "ArticleIdList": ["PMC5004565", "27579282"]}, {"Citation": "Kouchaki E, Tamtaji OR, Salami M, Bahmani F, Daneshvar Kakhaki R, Akbari E. et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017;36(5):1245\u20139. doi: 10.1016/j.clnu.2016.08.015.", "ArticleIdList": ["10.1016/j.clnu.2016.08.015", "27669638"]}, {"Citation": "Salami M, Kouchaki E, Asemi Z, Tamtaji OR. How probiotic bacteria influence the motor and mental behaviors as well as immunological and oxidative biomarkers in multiple sclerosis? A double blind clinical trial. J Funct Foods. 2019;52:8\u201313. doi: 10.1016/j.jff.2018.10.023.", "ArticleIdList": ["10.1016/j.jff.2018.10.023"]}, {"Citation": "Dargahi N, Matsoukas J, Apostolopoulos V. Streptococcus thermophilus ST285 alters pro-inflammatory to anti-inflammatory cytokine secretion against multiple sclerosis peptide in mice. Brain Sci. 2020;10(2):126. doi: 10.3390/brainsci10020126.", "ArticleIdList": ["10.3390/brainsci10020126", "PMC7071487", "32102262"]}, {"Citation": "\nFarber R, Xia Z. Prebiotic vs Probiotic in Multiple Sclerosis (MS). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04038541. Published July 31, 2019.\n"}, {"Citation": "\nNew High-Risk Pilot Projects Explore Probiotics, Virtual Reality, Repairing MS Damage, And Other Novel Solutions for People Affected by MS. National multiple sclerosis society. https://www.nationalmssociety.org/About-the-Society/News/New-High-Risk-Pilot-Projects-Explore-Probiotics-Vi. Published April 19, 2019. Accessed March 15, 2021.\n"}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "25"}, {"Year": "2021", "Month": "9", "Day": "13"}, {"Year": "2021", "Month": "9", "Day": "27"}, {"Year": "2022", "Month": "8", "Day": "8", "Hour": "3", "Minute": "25"}, {"Year": "2022", "Month": "8", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "9", "Day": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35935051", "PMC9348531", "10.34172/apb.2022.057"]}}], "PubmedBookArticle": []}